Texas A&M faculty and students are driven by the spirit of discovery and committed to pushing back the boundaries of knowledge. Research conducted at Texas A&M generated annual expenditures of more than $1.131 billion in fiscal year 2020, paced by research grants in the life sciences. Texas A&M ranked in the top 25 of the most recent National Science Foundation Higher Education Research and Development survey based on expenditures of more than $952 million in fiscal year 2019. The College of Science alone is responsible for more than $40 million of that research, including millions in indirect cost return that is reinvested in new and continuing projects.

$40 million in federal research funding

World renowned biological clocks research

Chemistry houses Texas A&M’s second Cancer Prevention and Research Institute of Texas (CPRIT) Scholar in Cancer Research

Two-thirds of Mathematics faculty have NSF grants

Ranked 13th nationally among public university math departments in research funding (TheBestSchools.org, 2016)

Physics & Astronomy is a partner in the Giant Magellan Telescope

Cyclotron Institute brings in $7 million annually in external research grants

Centers, Institutes & Laboratories

The College of Science is home to 20 centers and institutes as well as many specialized laboratories and active research groups, where innovation by our top researchers has led to groundbreaking discoveries and extraordinary answers to life’s ordinary questions.

Research News

Texas A&M Researcher: New Drug Could Be ‘Game Changer’ Against COVID-19

A drug created by a Texas A&M University professor could be the most effective treatment yet for patients with COVID-19, including more aggressive variants of the virus such as Delta and others.

The drug compound, called MPI8, has stopped the replication of the virus in laboratory tests. It was created by a Texas A&M research team led by biological chemist Wenshe Ray Liu, a 2018 Texas A&M Presidential Impact Fellow and holder of the Gradipore Chair in the Department of Chemistry.

The potential effectiveness of MPI8 led Sorrento Therapeutics of San Diego, Calif., to seek exclusive intellectual property rights to the ingredient. An agreement between [...]

Read more about Texas A&M Researcher: New Drug Could Be ‘Game Changer’ Against COVID-19Read More